Mesenchymal stem cells derived‐exosomes enhanced amniotic membrane extract promotes corneal keratocyte proliferation.
- Published in:
- Biotechnology Progress, 2024, v. 40, n. 4, p. 1, doi. 10.1002/btpr.3465
- By:
- Publication type:
- Article
Works matching IS 87567938 AND DT 2024 AND VI 40 AND IP 4
Results: 20
1
2
Optimizing glutamine concentration enhances ex vivo expansion of natural killer cells through improved redox status.
- Published in:
- Biotechnology Progress, 2024, v. 40, n. 4, p. 1, doi. 10.1002/btpr.3464
- By:
- Publication type:
- Article
3
Effects of green light supplementation with red and blue combinations of LED light spectrums on the growth and transcriptional response of Haematococcus pluvialis.
- Published in:
- Biotechnology Progress, 2024, v. 40, n. 4, p. 1, doi. 10.1002/btpr.3462
- By:
- Publication type:
- Article
4
Digital application for drug product potency target evaluation in biopharmaceutical manufacturing.
- Published in:
- Biotechnology Progress, 2024, v. 40, n. 4, p. 1, doi. 10.1002/btpr.3461
- By:
- Publication type:
- Article
5
GMP implementation of a hybrid continuous manufacturing process for a recombinant non‐mAb protein—A case study.
- Published in:
- Biotechnology Progress, 2024, v. 40, n. 4, p. 1, doi. 10.1002/btpr.3459
- By:
- Publication type:
- Article
6
Development of a high‐throughput scale‐down model in Ambr® 250 HT for plasmid DNA fermentation processes.
- Published in:
- Biotechnology Progress, 2024, v. 40, n. 4, p. 1, doi. 10.1002/btpr.3458
- By:
- Publication type:
- Article
7
Bioburden detection on surface and water samples in a rapid, ultra‐sensitive and high‐throughput manner.
- Published in:
- Biotechnology Progress, 2024, v. 40, n. 4, p. 1, doi. 10.1002/btpr.3457
- By:
- Publication type:
- Article
8
A modular and multi‐functional purification strategy that enables a common framework for manufacturing scale integrated and continuous biomanufacturing.
- Published in:
- Biotechnology Progress, 2024, v. 40, n. 4, p. 1, doi. 10.1002/btpr.3456
- By:
- Publication type:
- Article
9
Correction to "Soluble production and function of vascular endothelial growth factor/basic fibroblast growth factor complex peptide".
- Published in:
- 2024
- Publication type:
- Correction Notice
10
Modeling scalability of impurity precipitation in downstream biomanufacturing.
- Published in:
- Biotechnology Progress, 2024, v. 40, n. 4, p. 1, doi. 10.1002/btpr.3454
- By:
- Publication type:
- Article
11
Proteomic analysis of host cell protein fouling during bioreactor harvesting.
- Published in:
- Biotechnology Progress, 2024, v. 40, n. 4, p. 1, doi. 10.1002/btpr.3453
- By:
- Publication type:
- Article
12
Methods comparison of two‐dimensional gel electrophoresis for host cell protein characterization.
- Published in:
- Biotechnology Progress, 2024, v. 40, n. 4, p. 1, doi. 10.1002/btpr.3452
- By:
- Publication type:
- Article
13
Leveraging bioanalytical characterization of fractionated monoclonal antibody pools to identify aggregation‐prone and less filterable proteoforms during virus filtration.
- Published in:
- Biotechnology Progress, 2024, v. 40, n. 4, p. 1, doi. 10.1002/btpr.3451
- By:
- Publication type:
- Article
14
Measurement and control of foam generation in a mammalian cell culture.
- Published in:
- Biotechnology Progress, 2024, v. 40, n. 4, p. 1, doi. 10.1002/btpr.3450
- By:
- Publication type:
- Article
15
When will we have a clone? An industry perspective on the typical CLD timeline.
- Published in:
- Biotechnology Progress, 2024, v. 40, n. 4, p. 1, doi. 10.1002/btpr.3449
- By:
- Publication type:
- Article
16
Host cell proteins in monoclonal antibody processing: Control, detection, and removal.
- Published in:
- Biotechnology Progress, 2024, v. 40, n. 4, p. 1, doi. 10.1002/btpr.3448
- By:
- Publication type:
- Article
17
Fed‐batch performance profiles for mAb production using different intensified N − 1 seed strategies are CHO cell‐line dependent.
- Published in:
- Biotechnology Progress, 2024, v. 40, n. 4, p. 1, doi. 10.1002/btpr.3446
- By:
- Publication type:
- Article
18
Evaluating end‐to‐end continuous antibody manufacture with column‐free capture alternatives from economic, environmental, and robustness perspectives.
- Published in:
- Biotechnology Progress, 2024, v. 40, n. 4, p. 1, doi. 10.1002/btpr.3427
- By:
- Publication type:
- Article
19
Process development and characterization for integrated continuous bioprocesses—Highlights from N‐mAb.
- Published in:
- Biotechnology Progress, 2024, v. 40, n. 4, p. 1, doi. 10.1002/btpr.3425
- By:
- Publication type:
- Article
20
Issue Information.
- Published in:
- Biotechnology Progress, 2024, v. 40, n. 4, p. 1, doi. 10.1002/btpr.3360
- Publication type:
- Article